ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 115.00
-5.40 (-4.49%)
At close: Jan 2, 2026
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €9.37 billion as of January 2, 2026. Its market cap has increased by 1,872.69% in one year.
Market Cap
9.37B
Enterprise Value
8.86B
Revenue
5.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€115.00
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 9.37B, an increase of 4,536.16%. That is a compound annual growth rate of 43.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.06B |
| Sanofi | 101.00B |
| Sartorius Stedim Biotech | 20.20B |
| bioMérieux | 12.95B |
| Eurofins Scientific SE | 10.99B |
| Ipsen | 9.77B |
| Virbac | 3.00B |
| emeis Société anonyme | 2.33B |